Johnson & Johnson expects an increase in demand for its cancer drugs. On Tuesday, Johnson & Johnson first quarterly report beat analysts’ estimate and raised its full-year sales forecast on the strength of a growing demand for its cancer drugs…. Read More ›
In a paradigm shift, businesses are increasingly shifting from owning data centres to cloud computing, which is creating the basis for a new bull run. The combined revenues of Alphabet, Amazon and Microsoft have totaled to more than $100 billion… Read More ›
With lackluster performance of shares post IPO, offerings from Chinese firms have investors on their guard. With tepid investor demand, Chinese logistics firm, Best Inc, priced its U.S. initial public offering (IPO) at the bottom of expectations and in the… Read More ›
manageria.biz 